Molecular Profiling in Lung Cancer Patients

Clinical trial NCT00191308 · COMPLETED

Trial details

NCT number: NCT00191308
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Carcinoma

Start date: 2005-05-01
Primary completion: 2008-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.